The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)
Titel:
The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)
Auteur:
Skřičková, Jana Bortlíček, Zdeněk Hejduk, Karel Pešek, Miloš Zatloukal, Petr Kolek, Vítězslav Salajka, František Koubková, Leona Čoupková, Helena Zemanová, Milada